Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...
The results of the Precision-T Phase 3 study of investigational allogeneic T-cell immunotherapy, Orca-T, were published in the journal Blood.
The Supreme Court appeared sympathetic Monday to an internet service provider locked in a copyright battle with the music industry that some warn could leave millions of Americans disconnected and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback